MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 242 filers reported holding MYOKARDIA INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $680,000 | +56.0% | 3,077 | -34.3% | 0.00% | – |
| Q2 2020 | $436,000 | +2806.7% | 4,683 | +1332.1% | 0.00% | – |
| Q1 2020 | $15,000 | -96.5% | 327 | -94.4% | 0.00% | – |
| Q4 2019 | $424,000 | +99.1% | 5,811 | +41.8% | 0.00% | – |
| Q3 2019 | $213,000 | +0.5% | 4,098 | -3.4% | 0.00% | – |
| Q2 2019 | $212,000 | -85.5% | 4,243 | -84.9% | 0.00% | -100.0% |
| Q1 2019 | $1,460,000 | +5307.4% | 28,082 | +4978.1% | 0.00% | – |
| Q4 2018 | $27,000 | +28.6% | 553 | +71.2% | 0.00% | – |
| Q3 2018 | $21,000 | +75.0% | 323 | +38.0% | 0.00% | – |
| Q2 2018 | $12,000 | +1100.0% | 234 | +1070.0% | 0.00% | – |
| Q1 2018 | $1,000 | -99.2% | 20 | -99.3% | 0.00% | – |
| Q4 2017 | $127,000 | -25.7% | 3,010 | -24.8% | 0.00% | – |
| Q3 2017 | $171,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $38,586,000 | 34.31% |
| Copernicus Capital Management, LLC | 57,000 | $5,507,000 | 6.04% |
| Foresite Capital Management IV, LLC | 126,492 | $12,222,000 | 5.95% |
| Casdin Capital, LLC | 870,000 | $84,059,000 | 4.98% |
| Avoro Capital Advisors LLC | 1,880,000 | $181,646,000 | 3.59% |
| RTW INVESTMENTS, LP | 936,931 | $90,526,000 | 2.55% |
| Cormorant Asset Management, LP | 600,000 | $57,972,000 | 2.21% |
| Perceptive Advisors | 1,395,017 | $134,787,000 | 2.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $6,372,000 | 2.12% |
| Grace Capital | 24,400 | $2,358,000 | 2.02% |